Zea mays ZRP2 Regulatory Elements for Stable Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current transgenic plant production faces challenges in achieving consistent expression of multiple transgenes due to gene silencing and homology-based recombination, particularly when using repetitive promoter and 3' UTR elements, which can lead to undesirable effects such as reduced efficacy and unintended transcriptional inactivation.
Innovation Solution
The use of Zea mays ZRP2 regulatory elements, including specific promoters and 3' UTR sequences, to drive transgene expression in plant tissues, allowing for tissue-specific and developmental stage-specific expression patterns, thereby overcoming issues of gene silencing and promoting stable transgene integration and expression.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If repetitive promoter and 3' UTR elements are used to drive transgene expression, then transgene expression levels are improved, but gene silencing and homology-based recombination occur leading to reduced efficacy
Solution Approach 1:
The patent divides the regulatory elements into separate, non-repetitive components. Instead of using identical promoter and 3' UTR sequences for multiple transgenes, the invention employs distinct regulatory elements for each transgene, eliminating the homology that causes silencing and recombination while maintaining effective expression levels.
Solution Approach 2:
The patent applies different regulatory elements tailored to specific transgenes rather than using uniform repetitive elements. Each transgene is paired with unique promoter and 3' UTR sequences that are optimized for its specific expression needs, preventing homology-based issues while maintaining local expression efficiency.
2Productivity
If multiple transgenes are stacked at a single genomic locus, then productivity is improved, but gene silencing and homology-based recombination reduce efficacy
Solution Approach 1:
The patent segments the multiple transgenes with unique regulatory elements between them, preventing the formation of repetitive homology regions. This segmentation approach allows multiple transgenes to be stacked at a single locus while eliminating the conditions that lead to gene silencing and homology-based recombination.
Solution Approach 2:
The patent creates a composite structure where multiple transgenes are combined with diverse regulatory elements. This composite arrangement integrates different promoter and 3' UTR sequences that work together to maintain stable expression of multiple transgenes without the harmful effects of repetition.
3Productivity
If constitutive promoters are used for transgene expression, then expression levels are improved, but tissue-specific expression control is lost
Solution Approach 1:
The patent applies tissue-specific regulatory elements to specific transgenes based on their intended function and target tissue. This local quality approach ensures that each transgene is expressed in the appropriate tissue type at optimal levels, providing both high productivity and precise spatial control.
Data Source
AI summary
This disclosure concerns compositions and methods for promoting transcription and translation of a nucleotide sequence in a plant or plant cell, employing a promoter and/or a 3′UTR from Zea mays Zrp2 gene. Some embodiments relate to a promoter from a Zea mays Zrp2 gene that is operably linked to a Zea mays Ubiquitin 1 intron and functions in plants to promote transcription of operably linked nucleotide sequences. Other embodiments relate to a 3′ UTR from a Zea mays Zrp2 gene that functions in plants to terminate transcription of operably linked nucleotide sequences.